缪正秋.加用莨菪类药综合治疗重型肝炎647例疗效观察[J].中国中西医结合杂志,1988,(3):152-154,133 |
加用莨菪类药综合治疗重型肝炎647例疗效观察 |
Adding Scopelamines in Treating 647 Cases of Severe Hepatitis |
免费下载全文 查看/发表评论 下载PDF阅读器 |
|
DOI: |
中文关键词: 重型肝炎 综合治疗措施 甲皱微循环 肝肾综合征 莨菪类药 存活率 对照组 治疗后 医疗单位 静脉滴注 |
英文关键词: |
基金项目: |
|
摘要点击次数: 1261 |
全文下载次数: 842 |
中文摘要: |
在综合治疗基础上加用莨菪类药治疗647例重型肝炎(治疗组)存活率52.6%。而不加用莨菪类药治疗的360例重型肝炎(对照组)存活率28.3%(P<0.01)。治疗组患者尿量较多,发生肝肾综合征的较对照组明显减少.64.4%患者甲皱微循环有改善 |
英文摘要: |
This paper reports 1007 cases of severe hepatitis.Scopolamines(including anisodamine)was added to other comprehensive measures that were applied in 647 cases(treated group),and those treated with comprehensive therapy but without scopolamines(control group)were applied in 360 cases.The results showed that the survival rates of the treated and the control group were 52.6% and 28.3% respectively.It was also discovered that the patients in the treated group had larger amount of urine and that the incidence of hepatorenal syndrome was lower than that of the control. Disturbances of nail microcirculation were evidently alleviated with anisodamine or scopolamine. This kind of drug could evidently increase the survival rate.In addition to this,scopolamines produces few side-effect,is convenient in use and cheap in price. |
关闭 |